Abstract 11470: Effect of Sarpogrelate, a 5-HT2A Antagonist, on Platelet Aggregation in Patients With Stable Atherosclerotic Cardiovascular Disease: Potential for Practical Use at Preoperative Period

Introduction: Clopidogrel is a principal antiplatelet agent in patients with atherosclerotic cardiovascular disease (ASCVD). However, patients need to stop clopidogrel at least 5 days before surger...